nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—PTGS2—osteoarthritis	0.897	1	CbGaD
Etoricoxib—Celecoxib—PTGS2—osteoarthritis	0.00171	1	CrCbGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—BMP2—osteoarthritis	0.000688	0.00681	CbGpPWpGaD
Etoricoxib—CYP1A2—Estrogen Receptor Pathway—ESR1—osteoarthritis	0.000677	0.0067	CbGpPWpGaD
Etoricoxib—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—GSTO1—osteoarthritis	0.000674	0.00667	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—CTSK—osteoarthritis	0.000639	0.00632	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—MCF2L—osteoarthritis	0.000632	0.00625	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—FN1—osteoarthritis	0.00063	0.00623	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—SMAD3—osteoarthritis	0.000626	0.00619	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—CXCL8—osteoarthritis	0.000615	0.00608	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling mediated by p38-alpha and p38-beta—PTGS2—osteoarthritis	0.000609	0.00602	CbGpPWpGaD
Etoricoxib—MAPK14—Monoamine Transport—IL1B—osteoarthritis	0.000608	0.00602	CbGpPWpGaD
Etoricoxib—MAPK14—Endothelins—MMP1—osteoarthritis	0.000574	0.00568	CbGpPWpGaD
Etoricoxib—MAPK14—Oncostatin M Signaling Pathway—MMP1—osteoarthritis	0.00056	0.00554	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—ESR1—osteoarthritis	0.000559	0.00553	CbGpPWpGaD
Etoricoxib—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoarthritis	0.000542	0.00536	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—BMP2—osteoarthritis	0.000534	0.00529	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—MMP2—osteoarthritis	0.000534	0.00528	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—IGF1—osteoarthritis	0.000527	0.00521	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—IGF1—osteoarthritis	0.000511	0.00506	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL1A—osteoarthritis	0.00051	0.00505	CbGpPWpGaD
Etoricoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—FN1—osteoarthritis	0.000498	0.00493	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—COL2A1—osteoarthritis	0.000488	0.00482	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—LEP—osteoarthritis	0.000483	0.00478	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—MMP2—osteoarthritis	0.000468	0.00463	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—CXCL8—osteoarthritis	0.000466	0.00461	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—MMP1—osteoarthritis	0.000465	0.0046	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—MMP9—osteoarthritis	0.000462	0.00457	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—ESR1—osteoarthritis	0.000461	0.00456	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL1A—osteoarthritis	0.000451	0.00446	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—HSPA5—osteoarthritis	0.000442	0.00437	CbGpPWpGaD
Etoricoxib—MAPK14—Monoamine Transport—TNF—osteoarthritis	0.000442	0.00437	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000435	0.00431	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—SMAD3—osteoarthritis	0.000432	0.00427	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—TNF—osteoarthritis	0.000428	0.00423	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—MMP2—osteoarthritis	0.000428	0.00423	CbGpPWpGaD
Etoricoxib—MAPK14—IL-1 signaling pathway—IL1B—osteoarthritis	0.000395	0.0039	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—CXCL8—osteoarthritis	0.000389	0.00385	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CAMK2B—osteoarthritis	0.000387	0.00383	CbGpPWpGaD
Etoricoxib—MAPK14—Amyotrophic lateral sclerosis (ALS)—TNF—osteoarthritis	0.000385	0.00381	CbGpPWpGaD
Etoricoxib—CYP1A2—Phase II conjugation—GSTO1—osteoarthritis	0.000378	0.00374	CbGpPWpGaD
Etoricoxib—MAPK14—FGF signaling pathway—MMP9—osteoarthritis	0.000377	0.00373	CbGpPWpGaD
Etoricoxib—MAPK14—IL12-mediated signaling events—IL1B—osteoarthritis	0.000368	0.00364	CbGpPWpGaD
Etoricoxib—CYP2E1—Biological oxidations—GSTO1—osteoarthritis	0.000368	0.00364	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—IGF1—osteoarthritis	0.000364	0.00361	CbGpPWpGaD
Etoricoxib—CYP2E1—Metapathway biotransformation—GSTO1—osteoarthritis	0.000363	0.00359	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—SMAD3—osteoarthritis	0.000359	0.00356	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—TNF—osteoarthritis	0.000355	0.00351	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—HSPA5—osteoarthritis	0.000355	0.00351	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—FN1—osteoarthritis	0.000348	0.00344	CbGpPWpGaD
Etoricoxib—PTGS2—Overview of nanoparticle effects—IL6—osteoarthritis	0.000345	0.00342	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to RAS—IL6—osteoarthritis	0.000339	0.00336	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TIMP1—osteoarthritis	0.000338	0.00335	CbGpPWpGaD
Etoricoxib—MAPK14—AGE/RAGE pathway—MMP9—osteoarthritis	0.000321	0.00318	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—MMP1—osteoarthritis	0.000317	0.00314	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—osteoarthritis	0.000316	0.00312	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1A—osteoarthritis	0.00031	0.00306	CbGpPWpGaD
Etoricoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—TNF—osteoarthritis	0.000309	0.00306	CbGpPWpGaD
Etoricoxib—MAPK14—Leptin signaling pathway—IL1B—osteoarthritis	0.000308	0.00305	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TGFB1—osteoarthritis	0.000307	0.00303	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IGF1—osteoarthritis	0.000305	0.00302	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—COL9A2—osteoarthritis	0.0003	0.00296	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—CXCL8—osteoarthritis	0.000299	0.00296	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—COL9A1—osteoarthritis	0.000291	0.00288	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—FN1—osteoarthritis	0.00029	0.00287	CbGpPWpGaD
Etoricoxib—MAPK14—TWEAK Signaling Pathway—IL6—osteoarthritis	0.000287	0.00284	CbGpPWpGaD
Etoricoxib—MAPK14—Cardiac Hypertrophic Response—TNF—osteoarthritis	0.000286	0.00283	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL1A—osteoarthritis	0.000285	0.00282	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—GSTO1—osteoarthritis	0.000284	0.00281	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—osteoarthritis	0.000284	0.00281	CbGpPWpGaD
Etoricoxib—CYP2C19—Metapathway biotransformation—GSTO1—osteoarthritis	0.00028	0.00277	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—CRP—osteoarthritis	0.000277	0.00274	CbGpPWpGaD
Etoricoxib—MAPK14—Signalling to ERKs—IL6—osteoarthritis	0.000276	0.00273	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—CXCL8—osteoarthritis	0.000273	0.0027	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL1B—osteoarthritis	0.000266	0.00263	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1A—osteoarthritis	0.000262	0.0026	CbGpPWpGaD
Etoricoxib—MAPK14—TSLP Signaling Pathway—IL6—osteoarthritis	0.000262	0.00259	CbGpPWpGaD
Etoricoxib—MAPK14—IL6-mediated signaling events—IL6—osteoarthritis	0.000262	0.00259	CbGpPWpGaD
Etoricoxib—CYP2D6—Biological oxidations—GSTO1—osteoarthritis	0.000261	0.00258	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—GSTO1—osteoarthritis	0.000259	0.00256	CbGpPWpGaD
Etoricoxib—CYP2D6—Metapathway biotransformation—GSTO1—osteoarthritis	0.000257	0.00255	CbGpPWpGaD
Etoricoxib—CYP2C9—Metapathway biotransformation—GSTO1—osteoarthritis	0.000255	0.00253	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—CXCL8—osteoarthritis	0.000251	0.00248	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoarthritis	0.000246	0.00244	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—CXCL8—osteoarthritis	0.000245	0.00243	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL1B—osteoarthritis	0.000241	0.00238	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL1B—osteoarthritis	0.000235	0.00233	CbGpPWpGaD
Etoricoxib—MAPK14—MAP kinase activation in TLR cascade—IL6—osteoarthritis	0.000228	0.00225	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—GSTO1—osteoarthritis	0.000221	0.00219	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—osteoarthritis	0.000218	0.00216	CbGpPWpGaD
Etoricoxib—MAPK14—ATF-2 transcription factor network—IL6—osteoarthritis	0.000218	0.00216	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000218	0.00216	CbGpPWpGaD
Etoricoxib—CYP1A2—Metapathway biotransformation—GSTO1—osteoarthritis	0.000218	0.00216	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL1A—osteoarthritis	0.000216	0.00213	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—LEP—osteoarthritis	0.000215	0.00212	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000213	0.00211	CbGpPWpGaD
Etoricoxib—CYP2C19—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000212	0.0021	CbGpPWpGaD
Etoricoxib—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000211	0.00209	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CTSK—osteoarthritis	0.000207	0.00205	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—TGFB1—osteoarthritis	0.000207	0.00205	CbGpPWpGaD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TNF—osteoarthritis	0.000204	0.00202	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—TGFB1—osteoarthritis	0.000203	0.00201	CbGpPWpGaD
Etoricoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoarthritis	0.000197	0.00195	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—CXCL8—osteoarthritis	0.000196	0.00194	CbGpPWpGaD
Etoricoxib—CYP2C9—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000194	0.00192	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—FN1—osteoarthritis	0.000192	0.0019	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000189	0.00187	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL1B—osteoarthritis	0.000188	0.00186	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HSPA5—osteoarthritis	0.000183	0.00181	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—osteoarthritis	0.000183	0.00181	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—osteoarthritis	0.00018	0.00178	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—osteoarthritis	0.000177	0.00175	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—TNF—osteoarthritis	0.000175	0.00173	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TIMP1—osteoarthritis	0.000174	0.00172	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL1B—osteoarthritis	0.000173	0.00171	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—GSTO1—osteoarthritis	0.000171	0.00169	CbGpPWpGaD
Etoricoxib—CYP3A4—Metapathway biotransformation—GSTO1—osteoarthritis	0.000168	0.00167	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—IGF1—osteoarthritis	0.000168	0.00166	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—IL6—osteoarthritis	0.000168	0.00166	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—osteoarthritis	0.000165	0.00164	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoarthritis	0.000165	0.00163	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 cascade initiated on plasma membrane—IL6—osteoarthritis	0.000163	0.00161	CbGpPWpGaD
Etoricoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—osteoarthritis	0.000162	0.0016	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—IL1B—osteoarthritis	0.000161	0.0016	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88 dependent cascade initiated on endosome—IL6—osteoarthritis	0.000159	0.00157	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—osteoarthritis	0.000157	0.00155	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—IL6—osteoarthritis	0.000156	0.00154	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—CXCL8—osteoarthritis	0.000155	0.00154	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000155	0.00153	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—IL6—osteoarthritis	0.000153	0.00151	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—osteoarthritis	0.000152	0.00151	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—IL6—osteoarthritis	0.00015	0.00149	CbGpPWpGaD
Etoricoxib—MAPK14—MyD88-independent cascade—IL6—osteoarthritis	0.000144	0.00143	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CXCL8—osteoarthritis	0.000143	0.00141	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000141	0.0014	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—IL6—osteoarthritis	0.000141	0.00139	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoarthritis	0.000139	0.00138	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—FMOD—osteoarthritis	0.000139	0.00137	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—IL6—osteoarthritis	0.000138	0.00136	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL1B—osteoarthritis	0.000137	0.00135	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TNF—osteoarthritis	0.000136	0.00135	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IHH—osteoarthritis	0.000136	0.00134	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MCF2L—osteoarthritis	0.000136	0.00134	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—IL6—osteoarthritis	0.000136	0.00134	CbGpPWpGaD
Etoricoxib—MAPK14—Activated TLR4 signalling—IL6—osteoarthritis	0.00013	0.00128	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—MMP9—osteoarthritis	0.000129	0.00128	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—IL6—osteoarthritis	0.000128	0.00127	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoarthritis	0.000128	0.00127	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—TNF—osteoarthritis	0.000126	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TGFB1—osteoarthritis	0.000125	0.00124	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—SMAD3—osteoarthritis	0.000125	0.00124	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IHH—osteoarthritis	0.000124	0.00123	CbGpPWpGaD
Etoricoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—IL6—osteoarthritis	0.000122	0.00121	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoarthritis	0.000121	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CAMK2B—osteoarthritis	0.000121	0.00119	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CTSK—osteoarthritis	0.000121	0.00119	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—osteoarthritis	0.000121	0.00119	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoarthritis	0.000119	0.00118	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoarthritis	0.000119	0.00118	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—CXCL8—osteoarthritis	0.000117	0.00116	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TNF—osteoarthritis	0.000117	0.00116	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—FMOD—osteoarthritis	0.000116	0.00115	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	0.000113	0.00112	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—IL6—osteoarthritis	0.00011	0.00109	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—FMOD—osteoarthritis	0.00011	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Toll-Like Receptors Cascades—IL6—osteoarthritis	0.000109	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—MMP1—osteoarthritis	0.000108	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—LEP—osteoarthritis	0.000107	0.00106	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TGFB1—osteoarthritis	0.000106	0.00105	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	0.000106	0.00105	CbGpPWpGaD
Etoricoxib—PTGS2—Selenium Micronutrient Network—IL6—osteoarthritis	0.000101	0.001	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—osteoarthritis	0.000101	0.000997	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—COL9A2—osteoarthritis	9.96e-05	0.000986	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TNF—osteoarthritis	9.93e-05	0.000982	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—FN1—osteoarthritis	9.89e-05	0.000978	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—COL9A1—osteoarthritis	9.67e-05	0.000957	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CRP—osteoarthritis	9.65e-05	0.000954	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HSPA5—osteoarthritis	9.59e-05	0.000949	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTGES—osteoarthritis	9.49e-05	0.000938	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1RN—osteoarthritis	9.34e-05	0.000924	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFBI—osteoarthritis	9.23e-05	0.000913	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGES—osteoarthritis	8.93e-05	0.000883	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—IL6—osteoarthritis	8.72e-05	0.000862	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IGF1—osteoarthritis	8.66e-05	0.000857	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP2—osteoarthritis	8.55e-05	0.000846	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—FMOD—osteoarthritis	8.45e-05	0.000836	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—IL6—osteoarthritis	8.03e-05	0.000795	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—IL6—osteoarthritis	8.01e-05	0.000793	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—GSTO1—osteoarthritis	7.98e-05	0.00079	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—FMOD—osteoarthritis	7.77e-05	0.000769	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BGN—osteoarthritis	7.73e-05	0.000765	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—FMOD—osteoarthritis	7.71e-05	0.000762	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoarthritis	7.23e-05	0.000716	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGES—osteoarthritis	6.89e-05	0.000682	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoarthritis	6.76e-05	0.000668	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1A—osteoarthritis	6.72e-05	0.000665	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—GSTO1—osteoarthritis	6.68e-05	0.000661	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BMP2—osteoarthritis	6.63e-05	0.000656	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—IL6—osteoarthritis	6.59e-05	0.000652	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FMOD—osteoarthritis	6.58e-05	0.000651	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—BGN—osteoarthritis	6.47e-05	0.00064	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—MMP9—osteoarthritis	6.42e-05	0.000636	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—SMAD3—osteoarthritis	6.4e-05	0.000633	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGES—osteoarthritis	6.34e-05	0.000627	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—GSTO1—osteoarthritis	6.29e-05	0.000622	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGES—osteoarthritis	6.28e-05	0.000621	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—IL6—osteoarthritis	6.18e-05	0.000611	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—BGN—osteoarthritis	6.09e-05	0.000603	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CRP—osteoarthritis	5.62e-05	0.000556	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGES—osteoarthritis	5.37e-05	0.000531	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TGFB1—osteoarthritis	5.29e-05	0.000524	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—ESR1—osteoarthritis	5.22e-05	0.000516	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TGFB1—osteoarthritis	5.19e-05	0.000514	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FMOD—osteoarthritis	5.08e-05	0.000503	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—TNF—osteoarthritis	4.94e-05	0.000489	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTO1—osteoarthritis	4.85e-05	0.00048	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—BGN—osteoarthritis	4.7e-05	0.000465	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP3—osteoarthritis	4.6e-05	0.000455	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTO1—osteoarthritis	4.46e-05	0.000442	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTO1—osteoarthritis	4.43e-05	0.000438	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—BGN—osteoarthritis	4.32e-05	0.000428	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—BGN—osteoarthritis	4.29e-05	0.000424	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SMAD3—osteoarthritis	4.16e-05	0.000411	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGES—osteoarthritis	4.14e-05	0.00041	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—IL6—osteoarthritis	3.99e-05	0.000395	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SMAD3—osteoarthritis	3.79e-05	0.000375	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTO1—osteoarthritis	3.78e-05	0.000374	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BGN—osteoarthritis	3.66e-05	0.000362	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—LEP—osteoarthritis	3.55e-05	0.000352	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IL6—osteoarthritis	3.52e-05	0.000349	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL1B—osteoarthritis	3.5e-05	0.000347	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ESR1—osteoarthritis	3.39e-05	0.000336	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—FN1—osteoarthritis	3.35e-05	0.000332	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	3.03e-05	0.0003	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IGF1—osteoarthritis	2.94e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTO1—osteoarthritis	2.92e-05	0.000289	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BGN—osteoarthritis	2.83e-05	0.00028	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.77e-05	0.000274	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—osteoarthritis	2.36e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—osteoarthritis	2.36e-05	0.000234	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—osteoarthritis	2.14e-05	0.000211	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—osteoarthritis	2.05e-05	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—osteoarthritis	1.76e-05	0.000174	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—osteoarthritis	1.75e-05	0.000173	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—osteoarthritis	1.61e-05	0.000159	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—osteoarthritis	1.35e-05	0.000134	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—osteoarthritis	1.33e-05	0.000131	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—osteoarthritis	1.24e-05	0.000123	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—osteoarthritis	1.23e-05	0.000122	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—osteoarthritis	1.21e-05	0.00012	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—osteoarthritis	1.05e-05	0.000104	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—osteoarthritis	8.13e-06	8.04e-05	CbGpPWpGaD
